1. Home
  2. QCLS vs NEPH Comparison

QCLS vs NEPH Comparison

Compare QCLS & NEPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

QCLS

Q/C Technologies Inc.

N/A

Current Price

$3.82

Market Cap

31.1M

Sector

Health Care

ML Signal

N/A

Logo Nephros Inc.

NEPH

Nephros Inc.

HOLD

Current Price

$3.11

Market Cap

31.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
QCLS
NEPH
Founded
2014
1997
Country
United States
United States
Employees
2
N/A
Industry
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Medical/Dental Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
31.1M
31.0M
IPO Year
N/A
2004

Fundamental Metrics

Financial Performance
Metric
QCLS
NEPH
Price
$3.82
$3.11
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$6.00
AVG Volume (30 Days)
342.8K
21.0K
Earning Date
04-15-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
1000.00
EPS
N/A
0.11
Revenue
N/A
$18,789,000.00
Revenue This Year
N/A
$11.24
Revenue Next Year
N/A
$11.58
P/E Ratio
N/A
$27.87
Revenue Growth
N/A
32.67
52 Week Low
$2.50
$1.88
52 Week High
$8.17
$6.42

Technical Indicators

Market Signals
Indicator
QCLS
NEPH
Relative Strength Index (RSI) 52.41 50.21
Support Level $3.38 $2.77
Resistance Level $3.86 $3.18
Average True Range (ATR) 0.28 0.24
MACD 0.01 0.04
Stochastic Oscillator 41.91 60.44

Price Performance

Historical Comparison
QCLS
NEPH

About QCLS Q/C Technologies Inc.

Q/C Technologies Inc is engaged in building blockchain and cryptocurrency infrastructure that is faster and more energy-efficient through quantum-class laser-based computing. The company uses laser-based processors inspired by quantum technology that can solve complex problems. By combining photonic computing with cryptocurrency systems, the company creates powerful and sustainable solutions for the next generation of blockchain applications.

About NEPH Nephros Inc.

Nephros Inc is a commercial-stage company that develops and sells high-performance water solutions to the medical and commercial markets. In medical markets, it sells water filtration products and waterborne pathogen detection products. In commercial markets, the company manufactures and sells water filters that improve the taste and odor of water and reduce biofilm, bacteria, and scale build-up in downstream equipment. The company's subsidiary is engaged in the development of its second-generation hemodiafiltration system and other products focused on improving therapies for patients with renal disease. The company generates almost all of its revenue from product sales and a small amount from royalty revenue and other revenues.

Share on Social Networks: